Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
Completed No Results Available Drug: Irbesartan|Drug: Hydrochlorothiazide All Phase 4 400 Interventional Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double|Primary Purpose: Treatment Change from baseline in insulin resistance(MatsudaIndex)Week16|Change from baseline in insulin resist‐QuickiIndex Week16;Change from baseline in triglyc.,BP,hs‐CRP,albumin/creatinine ratio Week16;Changes from baseline‐Matsuda,QuickiIndex,BP,triglyc.,hs‐CRP&albumin/creatinine ratio Week28
Epistemonikos ID: 210f3c87ecc0c20c1a210d29e66760b98811dde2
First added on: May 04, 2024